APOL1 and COVID-19: It is possible that a pre-existing state of immune dysregulation (e.g., SLE, HIV, transplant immunity) may predispose or “prime” cytokine pathways to be triggered by COVID-19, resulting in cFSGS even in the absence of high-risk APOL1 mutations.